Pharmaceutical Research and Manufacturers of America
The Pharmaceutical Research and Manufacturers of America (PhRMA) is a leading trade association based in the United States, representing the innovative biopharmaceutical industry. Founded in 1958, PhRMA advocates for policies that foster medical innovation and improve patient access to life-saving medications. With a strong presence across major operational regions in the US, PhRMA focuses on key areas such as drug discovery, development, and market access. PhRMA's core services include research advocacy, policy development, and educational initiatives aimed at promoting the value of pharmaceuticals. The organisation is recognised for its commitment to advancing public health through innovation, evidenced by its members' contributions to groundbreaking therapies and vaccines. As a prominent voice in the biopharmaceutical sector, PhRMA plays a crucial role in shaping the future of healthcare and ensuring that patients benefit from the latest medical advancements.
DitchCarbon Score
How does Pharmaceutical Research and Manufacturers of America's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Membership Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaceutical Research and Manufacturers of America's score of 23 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmaceutical Research and Manufacturers of America's reported carbon emissions
The Pharmaceutical Research and Manufacturers of America (PhRMA), headquartered in the US, currently does not provide specific carbon emissions data, as indicated by the absence of reported figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the organisation. As a result, PhRMA's climate commitments and initiatives remain unclear, and there is no information available regarding their strategies for addressing carbon emissions or contributing to climate action. The lack of data may reflect broader industry trends where pharmaceutical organisations are increasingly recognising the importance of sustainability but may not yet have established comprehensive reporting frameworks. In summary, without specific emissions data or reduction initiatives, PhRMA's current stance on carbon emissions and climate commitments is not well-defined.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaceutical Research and Manufacturers of America is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
